Enlightenment Research, LLC Gilead Sciences, Inc. Transaction History

Enlightenment Research, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $463,360 - $580,640	-8,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $181,664 - $206,192	2,800 Added 53.85%	8,000 $581,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $351,988 - $379,756	5,200 New	5,200 $363,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $736,252 - $804,459	-11,600 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $696,000 - $794,135	11,600 New	11,600 $750,000
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $507,303 - $649,782	-8,100 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $283,452 - $311,788	4,600 Added 131.43%	8,100 $526,000
Q3 2019 Oct 16, 2019	SELL	$62.51 - $69.0 $225,036 - $248,400	-3,600 Reduced 50.7%	3,500 $222,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $439,277 - $492,597	7,100 New	7,100 $480,000
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $312,650 - $350,250	-5,000 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $302,700 - $395,000	5,000 New	5,000 $313,000

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.